Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
CompaniesAntengene Corporation LimitedAssetsATG-022ATG-207AnTenGagerTriGager
Signals
Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.
CARsgen Therapeutics Announces 2026 Interim Results
CompaniesCARsgen Therapeutics Holdings LimitedHuadong MedicineAssetszevor-celsatri-celCT0596CT1190BKJ-C2529KJ-C2632KJ-C2633KJ-C2634KJ-C2635Diseasesrelapsed or refractory multiple myelomaplasma cell leukemiagastric/gastroesophageal junction cancerpancreatic cancerB-cell lymphomaacute myeloid leukemiahepatocellular carcinoma
Protagonist Therapeutics Reports Granting of Inducement Awards - August 18, 2026
CompaniesProtagonist Therapeutics
Greenstone Biosciences Awarded Breakthrough T1D Grant to Advance Islet Cell Platform
CompaniesGreenstone BiosciencesBreakthrough T1DDiseasestype 1 diabetes
Genentech Marks Topping out Milestone for New Holly Springs, North Carolina Manufacturing Facility
CompaniesGenentechRocheDiseasesmetabolic conditionsobesity
Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
CompaniesCuravitLindus Therapeutics
Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock
CompaniesAmylyx Pharmaceuticals
EuBiologics seeks phase 1 trial of dual-target Alzheimer’s vaccine PADIVAX
CompaniesEuBiologicsAssetsPADIVAXDiseasesAlzheimer's disease
SK biopharmaceuticals settles US Xcopri patent dispute with generic maker MSN
CompaniesSK biopharmaceuticalsMSN LaboratoriesAssetsXcopricenobamateDiseasesepilepsy
Regulator says no causal link confirmed in reported Mounjaro pancreatitis cases
CompaniesMerck & Co.AssetsMounjaroWegovyDiseasespancreatitis
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
CompaniesPiramal Pharma LimitedYapan Bio Private Limited
Real-World IBS Study Links IBS-Smart® and Trio-Smart® Testing to Lower Use of Selected Diagnostic Procedures and Lower Captured Diagnostic Costs
CompaniesGemelli BiotechAssetsIBS-SmartTrio-SmartDiseasesirritable bowel syndrome
LG Chem begins preclinical studies of Genuv-licensed GNV205 for solid tumors
CompaniesLG ChemGenuvAssetsGNV205Diseasessolid tumors
Celltrion expands Asia presence as key products retain market lead
CompaniesCelltrionAssetsRemsimaTruximaHerzumaVegzelmaOmlycloStoboclo-OsenveltSteqeymaDiseasesautoimmune diseasesblood cancersbreast cancergastric cancermetastatic colorectal cancerallergic diseasesbone disorders
Proton therapy shows promise in early-stage lung cancer patients with IPF: SMC study
CompaniesSamsung Medical CenterDiseasesidiopathic pulmonary fibrosisnon-small cell lung cancer
ALS Nexus 2026 Brings the Global ALS Community Together Again
CompaniesThe ALS AssociationDiseasesamyotrophic lateral sclerosis (ALS)
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
CompaniesGenScript Biotech Corporation
Roche Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for Perjeta® (pertuzumab) for the neoadjuvant treatment of aggressive early stage breast cancer
CompaniesRoche Canadapan-Canadian Pharmaceutical Alliance (pCPA)AssetsPerjeta (pertuzumab)DiseasesHER2-positive, early breast cancer
Gravity Diagnostics Names Jeff Marma Regional Sales Manager
CompaniesGravity DiagnosticsQuest DiagnosticsMedEx Laboratories
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
CompaniesCellution BiologicsElutia Inc.AssetsSimpliDerm